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reported: CSA vs Age, CTDIvol vs CSA, DLP vs CSA, CTDIvol by 
Patient, DLP by Patient. 
 
Results: The mean scan length, DLP, CTDIvol and Effective 
Dose by Protocol were found for each protocol. The most 
significant result was that the DLP values from the Head & 
Neck protocol were tightly clustered but higher than one 
would normally expect. The mean DLP was a factor of 4 
greater than the head and neck reference level reported in 
the previous UK national (diagnostic CT) dose audit. 
 
 
 
Conclusion: The results from this CT dose audit can be used 
as local Radiotherapy Imaging Reference Levels (RIRL). They 
will be able to guide protocol optimisation, allow comparison 
with other similarly equipped radiotherapy departments and 
participation in regional and national audits. The higher than 
expected DLP values for the Head & Neck protocol 
highlighted here has prompted a reassessment of the 
scanning parameters and may lead to protocol optimisation. 
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Purpose or Objective: Radiation safety for softer flattening 
filter free (FFF) treatment beams when operating at their 
very high dose rates should be considered over that of their 
flattening filter (FF) counterparts. Existing shielding is usually 
adequate when replacing treatment units utilizing beams of 
FF only with FFF-beams of the same nominal energy(1). 
However, depending upon the existing shielding composition 
and thickness, workload, and occupancy factors, the 
instantaneous dose rate (IDR) may present a radiation safety 
concern. 
 
Material and Methods: A generalized analysis is presented 
with regards to replacing a unit which has only FF-beams to 
one with FFF-beams in a pre-existing bunker. Extra focus is 
placed on the situation that radiation levels around the 
treatment bunker are already at the radiation safety 
threshold for the unit being replaced. This threshold 
condition varies with the radiation safety regulations of the 
land. For example, the Canadian Nuclear Safety Commission 
(CNSC) imposes a condition that the IDR be less than 25 μSv/h 
to deem an area uncontrolled(3). The United States National 
Regulatory Council (US NRC) regulates the time averaged 
dose rate (TADR) to be less than 20μSv in any one hour(2).  
 
Results: It is demonstrated that in switching to FFF-beam 
treatment units that protection using existing shielding is 
maintained for annual and weekly equivalent dose protection 
levels. However, it is possible for the CNSC IDR condition to 
be exceeded at the highest dose rates for FFF-beams. Thus 
shielding modification should be considered along with the 
ALARA principle(4). An analysis of the latter point is 
presented in general and by example from such a treatment 
unit replacement at the London Regional Cancer Program. 
The US NRC regulation is not as stringent as the Canadian 
condition and is almost impossible to exceed if the conditions 
before replacement were met. The analysis of this result is 
presented in general. 
 
Conclusion: Care must be taken when considering 
thereplacement of radiation treatment units with FF-beams 
to those with FFF-beamswith respect to radiation protection. 
Radiation protection from the existingshielding is maintained 
for annual and weekly protection levels. However, IDR may 
present a radiation safety concern dependingupon radiation 
safety regulations in the country of its location. In 
Canada,the possibility exists that this threshold can be 
exceeded. The US NRCcondition is almost impossible to 
exceed. 
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Purpose or Objective: In image-guided radiotherapy, 
imaging dose varies greatly with the imaging technique. We 
here present imaging doses from planar and cone-beam CT 
(CBCT) imaging for three different on-board imaging 
techniques: the treatment beam line (TBL, 6 MV), a 
dedicated imaging beam line termed kView of nominally 1 MV 
(IBL), and a kilovoltage system (kVision) at 70-121 kV photon 
energy. We consider two collectives of patients with common 
IGRT indications: head-and-neck and prostate cancer. 
 
Material and Methods: In this study, we retrospectively 
analyzed imaging dose of 54 patients with head-and-neck 
cancer and 53 with prostate cancer treated in 2013. For all 
patients, the number of verification images (CBCT and axes) 
was determined, separately for the three systems (more than 
1000 images). The dose for each verification image was 
calculated in the Philips Pinnacle treatment planning system 
on a 2 mm grid using the collapsed cone algorithm. We 
evaluated the dose maximum and dose to the organs at risk, 
considering the total imaging dose, and for the techniques (6 
MV, IBL, kV, planar vs. CBCT) separately. 
 
Results: The calculated imaging doses are given in Table 1. 
Both the TBL and IBL modality entail considerable imaging 
dose, even for orthogonal axes. The maximum dose value for 
each image, averaged over all prostate patients, was 14.8 
cGy (6 MV CBCT)/ 2.8 cGy (19 %; 6 MV axes)/ 10.5 cGy (71 %; 
IBL CBCT)/ 2.1 cGy (14 %; IBL axes)/ 3.8 cGy (26 %; kV CBCT), 
where percentage values refer to the 6 MV CBCT dose. As can 
be seen, kV CBCT still amounts to 26 % the imaging dose from 
MV CBCT, and about twice the dose from IBL axes. Averaged 
over the collective of head-and-neck cancer patients, the 
maximum imaging dose was 8.4 cGy (6 MV CBCT)/ 2.6 cGy (31 
%; 6 MV axes)/ 6.2 cGy (74 %; IBL CBCT)/ 2.3 cGy (27 %; IBL 
axes)/ 0.9 cGy (11 %; kV CBCT). Here, the dose reduction 
from axial images was not as pronounced because less 
monitor units were used for MV CBCT. kV CBCT reduced the 
dose further because of low mAs values chosen by the auto-
exposure mechanism. 
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In our clinical setting, images were acquired at every second 
or third treatment fraction, resulting in a total median dose 
from imaging of 34.6 cGy for head-and-neck, and 70.6 cGy 
for prostate cancer patients. The relative frequency of the 
techniques and the contributions of the different techniques 
to the total imaging dose is shown in Figure 1. 
 
 
Conclusion: The contribution of planar images to the imaging 
dose is smaller than the dose due to megavoltage CBCT, but 
not negligible in the clinical routine due to the larger number 
of planar images. The kV imaging modality has very small 
overall contribution to the imaging dose, which mainly arises 
from 6 MV and IBL (the latter being more frequently 
employed and therefore more prominent in the dose 
contribution). 
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Purpose or Objective: In recent years, dosimetry in cone 
beam computed tomography (CBCT) has become an issue as 
the standard dose index used for CT dosimetry (CTDI100) fails 
to provide a satisfactory estimation of dose for CBCT scans. 
AAPM TG–111 proposed replacements of the CTDI100 with a 
measurement of a cumulative dose to address the problem. 
The cumulative dose for CBCT scans f(0) is a point dose 
measured using a small ionization chamber in the middle of a 
cylindrical PMMA, polyethylene, or water phantom of length 
≥450 mm to achieve scatter equilibrium. Although this 
method overcomes the limitations of CTDI100, the use of 
longer phantoms is impractical in the clinical environment. A 
practical approach based on using the standard CT dosimetry 
system was introduced to assess f(0). 
 
Material and Methods: A function called Gx(W)100 was 
introduced in this study. It was defined as the ratio of f(0) to 
a dose index f100(150), which was proposed for CBCT 
dosimetry and equals the cumulative dose averaged over the 
length of a standard 100 mm CT pencil ionization chamber 
and measured within standard 150 mm long PMMA CTDI 
phantoms. Monte Carlo BEAMnrc and DOSXYZnrc codes have 
been used to simulate the On-Board Imager (OBI) system, and 
to calculate f100(150) and f(0). Standard 150 mm CTDI 
phantoms were simulated to calculate f100(150), whereas 
infinitely long PMMA, polyethylene, and water phantoms 
were used for f(0). The phantoms were in different diameters 
to represent head and body of an adult patient, a body 
polyethylene phantom being equivalent to the ICRU–AAPM 
phantom. f100(150) and f(0) were measured at the centre 
and periphery of the phantoms using beams of width 40–500 
mm and beam qualities of 80–140 kV. Gx(W)100 was 
evaluated under different conditions with f100(150) and f(0) 
calculated with the same beam width (W) and at the same 
position (centre or periphery). 
 
Results: Under the different conditions, Gx(W)100 showed a 
weak dependency on tube voltage over the range 80-140 kV. 
Gx(W)100, however, was influenced by diameter and 
composition of the phantom. Therefore, a set of Gx(W)100 
functions based on the diameter and composition was 
developed to assess f(0) in a given long phantom from 
f100(150) measurements obtained within the short phantoms. 
Gx(W)100 provides a practical approach to avoid the use of 
long phantoms, which are impractical in the clinical 
environment, and hence simplify the AAPM method. Since the 
CT dosimetry system used for f100(150) is available 
worldwide, this approach could help to maintain the standard 
equipment. The Gx(W)100 functions used in this study have 
been applied to a CT scanner, and showed a weak 
dependency on the scanner type. This gave an indication that 
Gx(W)100 may be comparatively independent of the type of 
imaging system. 
 
Conclusion: Gx(W)100 function was proposed in this study, 
and was relatively independent of tube voltage and may be 
independent on the scanner type. Gx(W)100 allows 
measurement of f(0) using the AAPM method with standard 
CT dosimetry equipment. 
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Purpose or Objective: The CBCT(Cone-beam CT) is an image 
guided system verifying the precise location of tumor before 
the radiation treatment such as IMRT(Intensity-modulated 
radiotherapy) and SBRT(Stereotactic body radiotherapy) for 
accurate radiotherapy. However, the frequent use of CBCT 
scanning can induce the secondary tumor due to increase of 
radiation exposure to patients. With the CBCT scanning, 
treatment volume can be verified locally by changing the 
CBCT scan range. In this study, we evaluated regional organ 
dose according to CBCT scan range with Monte Carlo 
simulation. 
 
